Voltar
Revisão Revisado por pares
BIBTEX RIS

Micronutrient Safety

1990; Wiley; Volume: 587; Issue: 1 Linguagem: Romeno

10.1111/j.1749-6632.1990.tb00153.x

ISSN

1749-6632

Autores

John N. Hathcock, Jeanne I. Rader,

Tópico(s)

Climate Change and Health Impacts

Resumo

Annals of the New York Academy of SciencesVolume 587, Issue 1 p. 257-266 Part V. Infant Nutrition and Immunity, Safety, and Future Research Micronutrient Safety JOHN N. HATHCOCK, JOHN N. HATHCOCK Division of Nutrition Food and Drug Administration 200 C Street, SW (HFF-268) Washington, DC 20204Search for more papers by this authorJEANNE I. RADER, JEANNE I. RADER Division of Nutrition Food and Drug Administration 200 C Street, SW (HFF-268) Washington, DC 20204Search for more papers by this author JOHN N. HATHCOCK, JOHN N. HATHCOCK Division of Nutrition Food and Drug Administration 200 C Street, SW (HFF-268) Washington, DC 20204Search for more papers by this authorJEANNE I. RADER, JEANNE I. RADER Division of Nutrition Food and Drug Administration 200 C Street, SW (HFF-268) Washington, DC 20204Search for more papers by this author First published: 01 June 1990 https://doi.org/10.1111/j.1749-6632.1990.tb00153.xCitations: 5AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1Hathcock, J. N. 1989. High nutrient intakes—the toxicologist's view. J. Nutr. In press. Google Scholar 2Hathcock, J. N. 1985. Quantitative evaluation of vitamin safety. Pharmacy Times 51: 104–113. PubMedGoogle Scholar 3 Committee on Dietary Allowances, Food and Nutrition Board, National Research Council. 1980. Recommended Dietary Allowances. 9th edit. National Academy Press. Washington, DC. Google Scholar 4 Subcommittee on Criteria for Dietary Evaluation, Food and Nutrition Board, National Research Council. 1986. Nutrient Adequacy. National Academy Press. Washington, DC. Google Scholar 5Hathcock, J. N. 1989. Risk/benefit analysis for vitamin supplements. In Nutritional Toxicology. J. Hathcock, Ed. Vol. 3: 141–153. Academic Press. Orlando, FL. 10.1016/B978-0-12-332603-4.50013-5 Google Scholar 6Bauernfiend, J. C. 1980. The Safe Use of Vitamin A. A Report of the International Vitamin A Consultative Group (IVACG). The Nutrition Foundation. Washington, DC. Google Scholar 7Miller, D. R. & K. C. Hayes. 1982. Vitamin excess and toxicity. In Nutritional Toxicology. J. Hathcock, Ed. Vol. 1: 81–133. Academic Press. New York, NY. 10.1016/B978-0-12-332601-0.50008-5 Google Scholar 8Bendich, A. & L. Langseth. 1989. Safety of vitamin A. Am. J. Clin. Nutr. 49: 358–371. 10.1093/ajcn/49.2.358 CASPubMedWeb of Science®Google Scholar 9Hathcock, J. N., D. L. Hattan, M. Jenkins, J. McDonald, P. R. Sundaresan & V. Wilkening. Evaluation of vitamin A toxicity. Am. J. Clin. Nutr. In press. Google Scholar 10Underwood, B. A. 1986. The Safe Use of Vitamin A by Women during the Reproductive Years. International Life Sciences Institute/Nutrition Foundation. Washington, DC. Google Scholar 11Krasinski, S. D., R. M. Russell, C. L. Otradovec, J. A. Sadowski, S. C. Hartz, R. A. Jacob & R. B. McGandy. 1989. Relationship of vitamin A and vitamin E intake to fasting plasma retinol, retinol binding protein, retinyl esters, carotene, α-tocopherol, and cholesterol among elderly and young adults: Increased plasma retinyl esters among vitamin A-supplemented users. Am. J. Clin. Nutr. 49: 112–120. CASPubMedWeb of Science®Google Scholar 12Frumar, A. M., D. R. Meldrum & H. L. Judd. 1979. Hypercarotenemia in hypothalmic amenorrhea. Fertil. Steril. 32: 261–264. 10.1016/S0015-0282(16)44229-9 CASPubMedWeb of Science®Google Scholar 13Kemmann, E., S. A. Pasquale & R. Skaf. 1983. Amenorrhea associated with carotenemia. J. Am. Med. Assoc. 249: 296–929. 10.1001/jama.1983.03330310056029 Google Scholar 14Vakil, D. V., A. Ayiomamitis, N. Nizami & R. M. Nizami. 1985. Hypercarotenemia: A case report and review of the literature. Nutr. Res. 5: 911–917. 10.1016/S0271-5317(85)80178-0 Web of Science®Google Scholar 15Mathews-Roth, M. M. 1983. Amenorrhea associated with carotenemia. J. Am. Med. Assoc. 250: 731. 10.1001/jama.1983.03340060025015 CASPubMedWeb of Science®Google Scholar 16Bendich, A. & L. J. Machlin. 1988. Safety of oral intake of vitamin E. Am. J. Clin. Nutr. 48: 612–619. 10.1093/ajcn/48.3.612 CASPubMedWeb of Science®Google Scholar 17King, R. A. 1949. Vitamin E therapy in Dupuytren's contracture. J. Bone Joint Surg. 31B: 443. CASPubMedWeb of Science®Google Scholar 18Briggs, M. H. 1974. Vitamin E in clinical medicine. Lancet 1: 220. 10.1016/S0140-6736(74)92527-6 CASPubMedWeb of Science®Google Scholar 19Tsay, A. C., J. J. Kelley, B. Peng & N. Cook. 1978. Study on the effect of metavitamin E supplementation in man. Am. J. Clin. Nutr. 31: 831–837. PubMedWeb of Science®Google Scholar 20Hermann, W. J., Jr., K. Ward & J. Faucett. 1979. The effect of tocopherol on high-density lipoprotein cholesterol. Am. J. Clin. Pathol. 72: 848–852. 10.1093/ajcp/72.5.848 PubMedWeb of Science®Google Scholar 21Howard, D. R., C. A. Rundell & J. G. Batsakis. 1982. Vitamin E and serum lipids: a non-correlation. Am. J. Clin. Pathol. 77: 243–244. Web of Science®Google Scholar 22Cohen, M. & A. Bendich. 1986. Safety of pyridoxine—A review of human and animal studies. Toxicol. Lett. 34: 129–139. 10.1016/0378-4274(86)90202-X CASPubMedWeb of Science®Google Scholar 23Schaumberg, H., J. Kaplan, A. Windebank, N. Vick, S. Rasmus, D. Pleasure & M. J. Brown. 1983. Sensory neuropathy from pyridoxine abuse. N. Engl. J. Med. 309: 445–448. 10.1056/NEJM198308253090801 PubMedWeb of Science®Google Scholar 24Dalton, K. 1985. Pyridoxine overdose in premenstrual syndrome. Lancet 1: 1168–1169. 10.1016/S0140-6736(85)92480-8 CASPubMedWeb of Science®Google Scholar 25Parry, G. J. & D. E. Bredesen. 1985. Sensory neuropathy with low-dose pyridoxine. Neurology 35: 1466–1468. 10.1212/WNL.35.10.1466 CASPubMedWeb of Science®Google Scholar 26O'Brien, P. 1982. The premenstrual syndrome: A review of the present status of therapy. Drugs 24: 140–151. 10.2165/00003495-198224020-00004 CASPubMedWeb of Science®Google Scholar 27Stewart, M. L., J. T. McDonald, A. S. Levy, R. P. Schucker & D. P. Henderson. 1985. J. Am. Diet. Assoc. 85: 1585–1590. PubMedWeb of Science®Google Scholar 28Alhadeff, L., C. T. Gualtieri & M. Lipton. 1984. Toxic effects of water-soluble vitamins. Nutr. Rev. 42: 33–40. 10.1111/j.1753-4887.1984.tb02278.x CASPubMedWeb of Science®Google Scholar 29DiPalma, J. R. & D. M. Ritchie. 1977. Vitamin toxicity. Annu. Rev. Pharmacol. Toxicol. 17: 133–148. 10.1146/annurev.pa.17.040177.001025 CASPubMedWeb of Science®Google Scholar 30Danford, D. E. & H. N. Munro. 1980. Water-soluble vitamins. In The Pharmacological Basis of Therapeutics. A. G. Gilman, L. S. Goodman & A. Gilman, Eds. 1560–1582. Macmillan. New York, NY. Google Scholar 31Rhead, W. J. & G. N. Schrauzer. 1971. Risks of long term ascorbic overdose (letter). Nutr. Rev. 29: 262–263. CASPubMedGoogle Scholar 32Schrauzer, G. N. & W. J. Rhead. 1973. Ascorbic acid abuse: Effects of long term ingestion of excessive amounts on blood levels and urinary excretion. Int. J. Vitam. Nutr. Res. 43: 201–211. CASPubMedWeb of Science®Google Scholar 33Tsao, C. S. & P. Y. Leung. 1988. Urinary ascorbic acid levels following withdrawal of large doses of ascorbic acid in guinea pigs. J. Nutr. 118: 895–900. CASPubMedWeb of Science®Google Scholar 34Cochrane, W. A. 1965. Overnutrition in prenatal and neonatal life: A problem? Can. Med. Assoc. J. 93: 893–899. CASPubMedWeb of Science®Google Scholar 35Siegel, C., B. Barker & M. Kunstadtr. 1982. Conditioned oral scurvy due to megavitamin C withdrawal. J. Peridontol. 53: 453–455. 10.1902/jop.1982.53.7.453 CASPubMedWeb of Science®Google Scholar 36Hoffer, A. 1985. Ascorbic acid and kidney stones. Can. Med. Assoc. J. 132: 320. CASPubMedWeb of Science®Google Scholar 37Ringsdord, W. M. & E. Cheraskin. 1981. Nutritional aspects of urolithiasis. South. Med. J. 74: 41–46. 10.1097/00007611-198101000-00016 PubMedWeb of Science®Google Scholar 38Barness, L. A. 1975. Safety considerations with high ascorbic acid dosage. Ann. N.Y. Acad. Sci. 258: 523–528. 10.1111/j.1749-6632.1975.tb29311.x CASPubMedWeb of Science®Google Scholar 39Schrauzer, G. N., D. Ishmael & G. W. Kiefer. 1975. Some aspects of current vitamin C usage: Diminished high-altitude resistance following overdosage. Ann. N.Y. Acad. Sci. 258: 377–381. 10.1111/j.1749-6632.1975.tb29296.x CASPubMedWeb of Science®Google Scholar 40Guinta, J. L. 1983. Dental erosion resulting from chewable vitamin C tablets. J. Am. Dent. Assoc. 107: 253–256. 10.14219/jada.archive.1983.0239 PubMedWeb of Science®Google Scholar 41 National Nutrition Consortium. 1978. Vitamin-Mineral Safety, Toxicity, and Misuse. The American Dietetic Association. Chicago, IL. Google Scholar 42Metz, J., U. Hundertmark & I. Pevny. 1980. Vitamin C allergy of the delayed type. Contact Dermatitis 6: 172–174. 10.1111/j.1600-0536.1980.tb05592.x PubMedWeb of Science®Google Scholar 43Chandra, R. K. 1984. Excessive intake of zinc impairs immune responses. J. Am. Med. Assoc. 252: 1443–1446. CASPubMedWeb of Science®Google Scholar 44Klevay, L. M. 1975. The ratio of zinc to copper in diets in the United States. Nutr. Rep. Int. 11: 237–242. Web of Science®Google Scholar 45Beisel, W. R. 1982. Single nutrients and immunity. Am. J. Clin. Nutr. 35(Feb. Suppl): 417–468. CASPubMedWeb of Science®Google Scholar 46Brock, J. H. & T. Mainou-Fowler. 1986. Iron and immunity. Proc. Nutr. Soc. 45: 305–315. 10.1079/PNS19860068 CASPubMedWeb of Science®Google Scholar 47Good, M. F., L. W. Powell & J. W. Halliday. 1988. Iron status and cellular immune competence. Blood Rev. 45: 43–49. 10.1016/0268-960X(88)90007-0 Web of Science®Google Scholar 48Cantinieaux, B., J. Boelaert, C. Hariga & P. Fondu. 1988. Impaired neutrophil defense against Yersinia enterocolitica in patients with iron overload who are undergoing dialysis. J. Lab. Clin. Med. 111: 524–528. CASPubMedWeb of Science®Google Scholar 49Akbar, A. N., P. A. Fitzgerald-Bocarsly, M. DeSousa, P.J. Giardina, M. W. Hilgartner & R. W. Grady. 1986. Decreased natural killer activity in thalassemia major: A possible consequence of iron overload. J. Immunol. 136: 1635–1640. 10.4049/jimmunol.136.5.1635 CASPubMedWeb of Science®Google Scholar 50McEnery, J. T. 1971. Hospital management of acute iron ingestion. Clin. Toxicol. 4: 603–616. 10.3109/15563657108990983 CASPubMedWeb of Science®Google Scholar 51 Centers for Disease Control. Selenium intoxications—New York. Morbid. Mortal. Weekly Rep. 33: 157–158. Google Scholar 52Fox, M. R. S. & R. M. Jacobs. 1986. Human nutrition and metal ion toxicity. In Metal Ions in Biological Systems. Concepts on Metal Ion Toxicity. H. Sigel, Ed. Vol. 20: 201–227. Marcel Dekker. New York, NY. Google Scholar Citing Literature Volume587, Issue1Micronutrients and Immune Functions. Cytokines and MetabolismJune 1990Pages 257-266 ReferencesRelatedInformation

Referência(s)